Published in Medical Letter on the CDC and FDA, December 28th, 1998
The recommendation comes in the draft version of the CDC's "Guidelines for National HIV Case Surveillance, Including Monitoring for HIV Infection and Acquired Immunodeficiency Syndrome (AIDS)," released on December 10, 1998. They are not unexpected, given strong hints at the February 1998 Retrovirus conference by Kevin M. De Cock, director of the CDC's Division of HIV/AIDS Prevention, Surveillance, and Epidemiology, that the agency favored name-based reporting (see AIDS Weekly, February 16, 1998).
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.